Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT vs rt-PA for Hyperacute Single Perforating Artery Infarction
NCT07111559Phase 4Recruiting
- Sponsor
- Nippon Medical School
- Start
- Aug 2025
- Primary completion
- Mar 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin and clopidogrel in lacunar stroke (LACI) (2 arms), sponsored by Nippon Medical School. Primary endpoint: Excellent outcome at 3 months. Started Aug 2025; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
lacunar stroke (LACI)
Beyond the preview
Go deeper on NCT07111559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07111559.